» Articles » PMID: 33990954

Technological Tools and Strategies for Culturing Human Gut Microbiota in Engineered in Vitro Models

Overview
Publisher Wiley
Specialty Biochemistry
Date 2021 May 15
PMID 33990954
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

The gut microbiota directly impacts the pathophysiology of different human body districts. Consequently, microbiota investigation is an hot topic of research and its in vitro culture has gained extreme interest in different fields. However, the high sensitivity of microbiota to external stimuli, such as sampling procedure, and the physicochemical complexity of the gut environment make its in vitro culture a challenging task. New engineered microfluidic gut-on-a-chip devices have the potential to model some important features of the intestinal structure, but they are usually unable to sustain culture of microbiota over an extended period of time. The integration of gut-on-a-chip devices with bioreactors for continuous bacterial culture would lead to fast advances in the study of microbiota-host crosstalk. In this review, we summarize the main technologies for the continuous culture of microbiota as upstream systems to be coupled with microfluidic devices to study bacteria-host cells communication. The engineering of integrated microfluidic platforms, capable of sustaining both anaerobic and aerobic cultures, would be the starting point to unveil complex biological phenomena proper of the microbiota-host crosstalks, paving to way to multiple research and technological applications.

Citing Articles

Modulation of gut microbiome in response to the combination of Nissle 1917 and sugars: a pilot study using host-free system reflecting impact on interpersonal microbiome.

Heer K, Kaur M, Sidhu D, Dey P, Raychaudhuri S Front Nutr. 2024; 11:1452784.

PMID: 39502876 PMC: 11534610. DOI: 10.3389/fnut.2024.1452784.


Tracing the path of Quorum sensing molecules in cystic fibrosis mucus in a biomimetic in vitro permeability platform.

Garbero O, Sardelli L, Butnarasu C, Frasca E, Medana C, Dal Bello F Sci Rep. 2024; 14(1):25907.

PMID: 39472521 PMC: 11522324. DOI: 10.1038/s41598-024-77375-w.


Cultivating complexity: Advancements in establishing in vitro models for the mucus-adhering gut microbiota.

Calvigioni M, Mazzantini D, Celandroni F, Vozzi G, Ghelardi E Microb Biotechnol. 2024; 17(10):e70036.

PMID: 39435730 PMC: 11494453. DOI: 10.1111/1751-7915.70036.


Cellular and Microbial In Vitro Modelling of Gastrointestinal Cancer.

Zukauskaite K, Li M, Horvath A, Jarmalaite S, Stadlbauer V Cancers (Basel). 2024; 16(17).

PMID: 39272971 PMC: 11394127. DOI: 10.3390/cancers16173113.


Microfluidic gut-axis-on-a-chip models for pharmacokinetic-based disease models.

Kim R, Sung J Biomicrofluidics. 2024; 18(3):031507.

PMID: 38947281 PMC: 11210976. DOI: 10.1063/5.0206271.


References
1.
Imura Y, Yoshimura E, Sato K . Microcirculation system with a dialysis part for bioassays evaluating anticancer activity and retention. Anal Chem. 2012; 85(3):1683-8. DOI: 10.1021/ac302938q. View

2.
Vogt N, Kerby R, Dill-McFarland K, Harding S, Merluzzi A, Johnson S . Gut microbiome alterations in Alzheimer's disease. Sci Rep. 2017; 7(1):13537. PMC: 5648830. DOI: 10.1038/s41598-017-13601-y. View

3.
Mailhe M, Ricaboni D, Vitton V, Gonzalez J, Bachar D, Dubourg G . Repertoire of the gut microbiota from stomach to colon using culturomics and next-generation sequencing. BMC Microbiol. 2018; 18(1):157. PMC: 6201554. DOI: 10.1186/s12866-018-1304-7. View

4.
Cui J, Zheng X, Hou W, Zhuang Y, Pi X, Yang J . The study of a remote-controlled gastrointestinal drug delivery and sampling system. Telemed J E Health. 2008; 14(7):715-9. DOI: 10.1089/tmj.2007.0118. View

5.
Sardelli L, Pacheco D, Ziccarelli A, Tunesi M, Caspani O, Fusari A . Towards bioinspired models of intestinal mucus. RSC Adv. 2022; 9(28):15887-15899. PMC: 9064393. DOI: 10.1039/c9ra02368b. View